Detalhe da pesquisa
1.
Mood disorders in adults with epilepsy: a review of unrecognized facts and common misconceptions.
Ann Gen Psychiatry
; 23(1): 11, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433207
2.
The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?
Epilepsy Behav
; 148: 109435, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748414
3.
Onset of efficacy and adverse events during Cenobamate titration period.
Acta Neurol Scand
; 146(3): 265-275, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711112
4.
A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy.
Epilepsy Behav
; 126: 108483, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953337
5.
Randomized controlled trial of moderate cardiovascular exercise for patients with drug-resistant epilepsy.
Epilepsy Behav
; 124: 108335, 2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601232
6.
Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate.
Acta Neurol Scand
; 141(5): 397-404, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31894578
7.
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Epilepsia
; 60(12): 2437-2447, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755090
8.
Cannabinoids for epilepsy: What do we know and where do we go?
Epilepsia
; 59(2): 291-296, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29214639
9.
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Epilepsia
; 59(2): 479-491, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369348
10.
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307.
Epilepsia
; 59(4): 866-876, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574701
11.
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data.
Epilepsia
; 59(9): 1727-1739, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047129
12.
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Epilepsy Behav
; 82: 119-127, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29604484
13.
Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes.
Neuromodulation
; 21(8): 797-804, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608227
14.
Medical management of refractory epilepsy--practical treatment with novel antiepileptic drugs.
Epilepsia
; 55 Suppl 1: 3-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24400690
15.
Perampanel for adjunctive treatment of partial-onset seizures: a pooled dose-response analysis of phase III studies.
Epilepsia
; 55(3): 423-31, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24605793
16.
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
Epilepsia
; 55(7): 1058-68, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24867391
17.
Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Epilepsy Behav
; 41: 164-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25461210
18.
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
Epilepsia
; 54(1): 126-34, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22905878
19.
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Epilepsia
; 54(3): 551-63, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23350722
20.
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
Epilepsia
; 54(8): 1481-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23663001